Trials / Conditions / Cystitis, Interstitial

Cystitis, Interstitial

25 registered clinical trials studyying Cystitis, Interstitial — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment NCT06299683	Vanderbilt University Medical Center	N/A
Completed	Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide NCT05260112	University of Pennsylvania	N/A
Completed	Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era NCT05752344	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Completed	Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome NCT04275297	Vanderbilt University Medical Center	N/A
Active Not Recruiting	Bladder Directed vs. Pelvic Floor Therapy in IC/BPS NCT02870738	Corewell Health East	Phase 2
Terminated	Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain NCT02781103	Kenneth M Peters, MD	N/A
Unknown	A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladde NCT02868775	Philadelphia Urosurgical Associates	—
Terminated	A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis NCT02787083	Philadelphia Urosurgical Associates	Phase 3
Completed	Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis NCT02497976	ICStudy, LLC	Phase 3
Completed	A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome NCT02411110	Allergan	Phase 2
Completed	A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions NCT02395042	Allergan	Phase 2
Completed	Chronic Pain Risk Associated With Menstrual Period Pain NCT02214550	Endeavor Health	Phase 4
Completed	A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Inters NCT01613586	Astellas Pharma Europe B.V.	Phase 2
Completed	The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction NCT01482676	Insel Gruppe AG, University Hospital Bern	—
Terminated	A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bla NCT01060254	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2
Terminated	A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome NCT00999518	Pfizer	Phase 2
Unknown	DMSO Efficacy in IC/PBS Patients During and After Treatment NCT01074567	Assaf-Harofeh Medical Center	N/A
Withdrawn	Treatment of Interstitial Cystitis/Painful Bladder Syndrome Using Alternative Techniques: Exercise, Meditation NCT00661050	Stanford University	—
Completed	An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis NCT00601484	Pfizer	Phase 2
Completed	Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. NCT00775281	Insel Gruppe AG, University Hospital Bern	—
Terminated	Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis NCT00380783	Allergan	Phase 2
Withdrawn	Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis NCT00275379	Wyeth is now a wholly owned subsidiary of Pfizer	N/A
Completed	Linkage Analysis in Interstitial Cystitis NCT00675298	Beth Israel Deaconess Medical Center	—
Completed	Events Preceding Interstitial Cystitis (EPIC) NCT00248664	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	—
Completed	Diagnostic Challenges in IC (and Male CPPS) NCT00672087	Beth Israel Deaconess Medical Center	—